“…RGD peptide, as has been previously reported, has a comparatively low level effect on the inhibition of integrin activity and the prevention of PCO (Nishi et al, 1997a). Indeed, the potency of disintegrins is 500±2000 times higher at inhibiting platelet aggregation (Musial et al, 1990;Jia et al, 1997) and 150±300 times higher at inhibiting retinal pigment epithelial cell attachment to the ECM than the small RGD peptides (Yang et al, 1996). Most of the ECM proteins, such as ®bronectin, laminin, The in¯ammatory conditions of anterior chamber (Hogan et al, 1959) (Nagata and Watanabe, 1996): Grade I (no opaci®cation or limited to less than one quadrant of the posterior capsule periphery), Grade II (opaci®cation extending beyond one quadrant of the periphery but not invading the papillary region).…”